SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs quarterly results and forward guidance are the main focus, with traders debating whether data-center demand can offset concerns about PC demand and broader chip weakness after Intels cautious outlook. The community is split between hopes that a strong report could lift semiconductor stocks and fears that shares may fall even on a beat if guidance disappoints or market sentiment stays weak.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is drawing attention ahead of its quarterly earnings report, with traders weighing its favorable preliminary revenue and margin update against the need for confirmation, stronger forward guidance, and improved cash flow. Bulls expect a strong report to help the shares recover, while skeptics point to thin margins, cash burn, and lingering distrust of management, noting that the stock has remained weak despite the upbeat update.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Anticipation of the FDAs November 22 decision on Capricors Duchenne muscular dystrophy therapy deramiocel is driving attention, with traders debating whether its HOPE-3 upper-limb data could support approval and whether heavy short interest could amplify the move. Optimists point to physician support and recent FDA flexibility in another rare-disease case, while skeptics cite the negative advisory committee outcome and statistical concerns; approval remains uncertain.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Midterm-election outcomes are driving the discussion, with traders debating whether a Republican showing could support DJT or a Democratic blue wave could pressure the Trump-linked stock. Some point to election-related hopes and possible short covering behind the gains, while others expect a selloff and question the companys fundamentals.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs Q3 results and Q4 outlook drew attention, with traders calling the report strong but reacting to a sharp, volatile post-earnings selloff. The debate centers on whether AI data-center connectivity growth justifies the valuation or whether expectations were already too high.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include core, cognitive adjacencies, and cognitive networks. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista is drawing attention ahead of its quarterly earnings report, with traders positioning for a potentially sharp move after a steep pullback. Bulls expect AI and hyperscaler networking demand to support results, while skeptics worry about capex uncertainty and the stocks history of selling off after earnings.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

WULFs sharp decline alongside AI and data-center peers, with traders focused on earnings risk and concerns about heavy spending, financing, and execution. Bulls point to its AI/HPC contracts and high short interest, while bears see continued downside in the sector selloff.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingos post-earnings selloff is drawing attention after investors focused on softer-than-expected next-quarter revenue guidance despite solid results and accelerating daily-user growth. Bulls argue engagement and the long-term business remain strong, while bears question whether user growth can translate into revenue and justify the valuation amid AI competition concerns.

Toast, Inc. engages in the development and provision of consumer payment application for restaurants. It offers terminals, kiosk, guest facing display, and system accessories. The firm also offers point of sale, reporting and analytics, online ordering and delivery, and kitchen display system. The company was founded by Jonathan Grimm, Aman Narang, and Stephen J. Fredette in December 2011 and is headquartered in Boston, MA.

Toast Inc - Ordinary Shares - Class A

Toast Inc

Toasts quarterly report is driving attention: traders point to continued growth and raised full-year profit guidance, while noting an earnings-per-share miss against expectations. The community is split between optimism about the business and concern that the stock may sell off after results, as it has in past earnings periods.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Rafael Holdings subsidiary has submitted an NDA for Trappsol Cyclo, another Niemann-Pick type C treatment, drawing attention to whether the FDA will accept the application despite the trials missed primary endpoint. Traders debate whether the drug could become a competitor to Zevras MIPLYFFA or offer a complementary option; the FDAs filing and review decisions remain uncertain.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vantage Group Holdings Launches Facultative Reinsurance Business; Appoints Lisa Pickard as President

Vantage Group Holdings Launches Facultative Reinsurance Business; Appoints Lisa Pickard as President Vantage Group Holdings Launches Facultative Reinsurance Business; Appoints Lisa Pickard as PresidentPR NewswireHAMILTON, Bermuda, Nov. 3, 2026 Industry veteran brings deep underwriting and executive...

Howard Hughes' MPC Business Grows: Can Land Sales Stay Strong?

HHH's MPC earnings surge 32% in Q2 2026, fueled by robust residential land sales and rising homebuyer demand. Can the momentum continue?

Howard Hughes vs. Brookfield: Which Stock Offers Better Value Today?

HHH and BN offer diversified growth opportunities, but their earnings momentum, capital strength and investment risks set them apart.

Analysts Estimate Howard Hughes Holdings (HHH) to Report a Decline in Earnings: What to Look Out for

Howard Hughes Holdings (HHH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Howard Hughes Holdings Set to Join S&P SmallCap 600

Howard Hughes Holdings Set to Join S&P SmallCap 600 Howard Hughes Holdings Set to Join S&P SmallCap 600PR NewswireNEW YORK, Oct. 23, 2026 NEW YORK, Oct. 23, 2026 /PRNewswire/ -- Howard Hughes Holdings Inc. (NYSE:HHH) will replace Arcosa Inc. (NYSE: ACA) in the S&P SmallCap 600 effective prior to...

Bill Ackman Is Directing Up to $3 Billion Into Howard Hughes' Insurance Arm, Vantage, as Part of His Plan to Build a Modern Berkshire Hathaway. Is HHH Stock the Way to Play His Buffett Ambitions?

Key PointsLast month, Pershing Square's Bill Ackman openly discussed his plans to turn Howard Hughes Holdings into an investment holding company...

Howard Hughes Stock Falls 9.3% YTD: Is the Dip a Buying Opportunity?

HHH stock declines 9.3% YTD amid high financing costs and competition, but rising home sales and a $2.1B Vantage deal offer fresh growth opportunities.

Howard Hughes Holdings Q2 2026 Earnings Call Transcript

Howard Hughes Holdings (NYSE:HHH) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below.
This content is powered by Benzinga APIs. For comprehensiveread more...

Bill Ackman Called Howard Hughes Holdings a 'Compounding Machine' He Wants to Turn Into a Trillion-Dollar Business Over the Next 50 Years. Here's Why the Market Might Be Underpricing That Bet.

Key PointsBill Ackman's Pershing Square bought a controlling stake of Howard Hughes last year at a premium price...

Cyrela Brazil Realty (CYRBY) Stock Jumps 5.8%: Will It Continue to Soar?

Cyrela Brazil Realty (CYRBY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in FFO estimate revisions may not translate into further price increase in the near term.

Howard Hughes Holdings Inc. is a holding company. It operates through the following segments: Operating Assets, MPCs, and Strategic Developments. The Operating Assets segment includes investments in unconsolidated ventures. The MPC segment is involved in the horizontal development of residential land and selling the improved acreage to homebuilders for the eventual sale of homes to new residents. The Strategic Developments segment focuses on building commercial properties at the appropriate time using the cash flow harvested from the sale of land to homebuilders which helps mitigate development risk. The company was founded on June 9, 2023 and is headquartered in The Woodlands, TX.

Howard Hughes Holdings Inc

Bill Ackman's Pershing Square Just Got A Buy Rating From Citi — What's The Howard Hughes Connection?

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Pershing Square announced on Monday that it would invest $900 million in Howard Hughes Holdings by purchasing 9 million shares of the company.</li><li>As part of the deal, Pershing Square will provide HHH with investment, advisory, and other support services to aid its transformation.</li><li>Howard Hughes will also pay Pershing Square a quarterly base fee of $3.75 million, along with a management fee equal to 0.375% of any increase in the company's equity market capitalization above its reference market cap.</li></ul>Bill Ackman’s Pershing Square Inc. (PS) received a ‘Buy’ rating from analysts at Citi, citing multiple levers available to the investment firm for its bullish outlook.According to TheFly, Citi initiated its coverage of Pershing Square with a ‘Buy’ rating and a $50 price target, implying a potential upside of over 40% from current levels.<a href="https://stocktwits.com/symbol/PS">Pershing Square shares</a> were up nearly 1% in Tuesday’s pre-market session.<h2 class="st-heading-2">PS’ Howard Hughes Connection</h2>Citi sees fees from Howard Hughes and new fundraising initiatives as potential catalysts for the shares. The firm added that the company's permanent capital base and high level of recurring fee revenue support the stock’s valuation.Pershing Square announced on Monday that it would invest $900 million in Howard Hughes Holdings Inc. (HHH) through the purchase of nine million shares of the company.Ackman has also been named the Executive Chairman of the HHH Board of Directors, and Pershing Square’s Chief Investment Officer, Ryan Israel, will take up the same role at Howard Hughes, the company announced.As part of the deal, Pershing Square will provide HHH with investment, advisory, and other support services to aid its transformation, including corporate development, transaction execution, and capital markets expertise. The firm will also help identify and hedge macroeconomic risks.Howard Hughes will also pay Pershing Square a quarterly base fee of $3.75 million, along with a management fee equal to 0.375% of any increase in the company's equity market capitalization above its reference market cap.<h2 class="st-heading-2">Ackman’s Berkshire Ambitions For Howard Hughes</h2>Billionaire investor Ackman outlined his Berkshire Hathaway ambitions for Howard Hughes while raising his bid for the latter.“We will make available the full resources of Pershing Square to HHH to build a diversified holding company, or one could say, a modern-day Berkshire Hathaway,” Ackman said in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/BillAckman/status/1891957378603491339">post</a> on X in February this year.He added that the new HHH will build a portfolio of controlling positions in public and private companies that meet Pershing Square's definition of high-quality businesses.“Owning small and growing MPCs that will eventually become large cities in the best pro-business markets in the country is a great long-term business.&nbsp; It's a lot better than a dying textile company,” Ackman added.During an interview with CNBC on Monday, Ackman also stated that it is highly likely that Pershing Square would build or buy an insurance company for Howard Hughes, mirroring Berkshire Hathaway.<h2 class="st-heading-2">What Are Other Wall Street Analysts Saying About PS?</h2>UBS launched coverage of Pershing Square with a ‘Neutral’ rating and $39 price target. The firm said the company's largely permanent capital structure provides durable fee revenue and supports long-term net asset value (NAV) compounding, but noted that the stock's current valuation already captures much of that benefit.RBC Capital analyst Kenneth Lee initiated Pershing Square with a ‘Sector Perform’ rating and a $40 price target, praising the company's longstanding investment success and fee-generating business model. Still, Lee believes much of that strength is already reflected in the share price.Analysts at Wells Fargo see a balanced risk-reward setup for Pershing Square, pointing to fundraising uncertainty and upcoming lock-up expirations as concerns. The firm has a price target of $37 with an ‘Equal Weight’ rating.<a href="https://stocktwits.com/symbol/PS">PS stock</a> is up 49% year-to-date, while HHH stock is down 20%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/lunr-stock-gained-nearly-50-in-month-behind-relentless-investor-optimism/cZga63qRepA">LUNR Stock Has Gained Nearly 50% In A Month — A Look At What's Behind The Relentless Investor Optimism</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bill Ackman attends Legion of Honour Award Ceremony and Dinner for Olivia Tournay Flatto at the Park Avenue Armory on October 19, 2022 in New York City. (Photo by Sylvain Gaboury/Patrick McMullan via Getty Images)

Bill Ackman’s Pershing Square Inc. (PS) received a ‘Buy’ rating from analysts at Citi, citing multiple levers available to the investment firm for its bullish outlook.

Citi initiated its coverage of Pershing Square with a ‘Buy’ rating and a $50 price target, implying a potential upside of over 40% from current levels.

Current Price	$76.30
Prev Close	$77.91
Open	$77.50
Dividend Yield	0.00%
50-Day Moving Average	$68.14
Beta	0.93
Avg. Volume	925,340.42
PE Ratio	15.78

52-Week High	$91.07
52-Week Low	$60.09
Market Capitalization	$4.65B
EPS (Annual)	$2.21
Price to Book	1.17
Revenue Per Employee	$2.95M

Feed

News

Sentiment

Earnings

Fundamentals

Info

HHH Fundamentals